Financial reports
10-Q
2024 Q2
Quarterly report
18 Mar 24
10-Q
2024 Q1
Quarterly report
14 Dec 23
10-K
2023 FY
Annual report
25 Oct 23
10-Q
2023 Q3
Quarterly report
14 Jun 23
10-Q
2023 Q2
Quarterly report
15 Mar 23
10-Q
2023 Q1
Quarterly report
14 Dec 22
10-K
2022 FY
Annual report
27 Oct 22
40-F/A
2021 FY
Annual report (Canada) (amended)
16 Nov 21
40-F
2021 FY
Annual report (Canada)
29 Oct 21
Current reports
8-K
Submission of Matters to a Vote of Security Holders
31 Jan 24
8-K
BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
20 Dec 23
8-K
Condesed Interim Financial Statements
14 Dec 23
8-K
BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
30 Nov 23
8-K
Regulation FD Disclosure
3 Nov 23
8-K
Statement of Financial Position
25 Oct 23
8-K
BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer
8 Sep 23
8-K
Amendments to Articles of Incorporation or Bylaws
7 Sep 23
8-K
Briacell Therapeutics Corp. Announces Closing of
31 Aug 23
8-K
Briacell Therapeutics Corp. Announces Closing of
31 Aug 23
Registration and prospectus
S-3
Shelf registration
22 Jan 24
POS AM
Prospectus update (post-effective amendment)
20 Mar 23
424B3
Prospectus supplement
21 Mar 22
POS AM
Prospectus update (post-effective amendment)
10 Mar 22
424B3
Prospectus supplement
26 Nov 21
POS AM
Prospectus update (post-effective amendment)
19 Nov 21
424B3
Prospectus supplement
18 Oct 21
424B3
Prospectus supplement
25 Jun 21
D
$27.2M in equity / options / securities to be acquired, sold $27.2M, 12 investors
15 Jun 21
F-1
Registration statement (foreign)
15 Jun 21
Proxies
Other
EFFECT
Notice of effectiveness
1 Feb 24
CORRESP
Correspondence with SEC
29 Jan 24
UPLOAD
Letter from SEC
29 Jan 24
EFFECT
Notice of effectiveness
29 Mar 23
UPLOAD
Letter from SEC
16 Mar 23
CORRESP
Correspondence with SEC
13 Mar 23
UPLOAD
Letter from SEC
8 Mar 23
EFFECT
Notice of effectiveness
17 Mar 22
EFFECT
Notice of effectiveness
24 Nov 21
EFFECT
Notice of effectiveness
25 Jun 21
Ownership
SC 13G/A
Lynwood Capital Management Inc.
14 Feb 23
4
Jamieson Bondarenko
28 Dec 22
4
William V. Williams
28 Dec 22
4
Jamieson Bondarenko
20 Dec 22
3
Jamieson Bondarenko
11 Aug 22
3
Marc Lustig
2 Aug 22
3
Priore Giuseppe Del
1 Aug 22
3
Rebecca Taub
1 Aug 22
3
Miguel A. Lopez-Lago
1 Aug 22
3
Martin E. Schmieg
1 Aug 22